JW (Cayman) Therapeutics Co. Ltd

HK$2.50As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2126Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 6Y CAGR (31.98%)
Div yield —
ROE (49.74%)
Biotechnology
Beta (5Y) 1.81
PE TTM —
TSR TTM (28.16%)
Mkt cap HK$1.015B
ROIC (14.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.17
26.99%
(61.56%)
Hold 4|8|7|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.03
0.04
0.04
0.04
(2.54%)
2.40%
9.61%
24.13%
Revenue¥M
83.01
81.01
83.73
84.51
11.76%
5.11%
3.17%
(0.66%)
Peers (US$129.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.607
(0.017)
(0.017)
EBIT/Intx
0.365
0.232
0.211
Own earn%
2.20
107.95
109.55
Sh yield%
35.71
16.67
18.11
Owners
Insiders/Inst%
11.80
26.39
Short interest%
2.70
SBC / revenue%
4.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
21–25
$1 testx
1.4
Incr. ROIC%
7